Suchergebnisse - (Person:"Spalluto, Giampiero")

PubPharm (12)

1

Targeting G Protein-Coupled Receptors with Magnetic Carbon Nanotubes : The Case of the A3 Adenosine Receptor

enthalten in: ChemMedChem | 2020

von Pineux, F. | Federico, S. | Klotz, K. | +7

2

1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists : Modifications at the 8 position to reach selectivity towards A3 adenosine receptor subtype

enthalten in: European journal of medicinal chemistry | 2018

von Federico, S. | Margiotta, E. | Salmaso, V. | +5

3

Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors : a preliminary structure-activity relationship study

enthalten in: Journal of medicinal chemistry | 2014

von Federico, S. | Ciancetta, A. | Porta, N. | +6

4

Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry

enthalten in: Biochemical pharmacology | 2012

von Kozma, E. | Kumar, T. | Federico, S. | +7

5

Does the combination of optimal substitutions at the C²-, N⁵- and N⁸-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A₃ adenosine receptors?

enthalten in: Bioorganic & medicinal chemistry | 2011

von Cheong, S. | Dolzhenko, A. | Paoletta, S. | +8

6

Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach : An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites

enthalten in: Bioorganic & medicinal chemistry | 2009

von Michielan, L. | Bolcato, C. | Federico, S. | +9

7

A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro

enthalten in: British journal of pharmacology | 2006

von Pugliese, A. | Coppi, E. | Spalluto, G. | +2

8

Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations

enthalten in: Journal of medicinal chemistry | 2006

von Pastorin, G. | Da Ros, T. | Bolcato, C. | +7

9

Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity

enthalten in: Current pharmaceutical design | 2006

von Moro, S. | Deflorian, F. | Bacilieri, M. | +1

10

Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists : pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study

enthalten in: Journal of medicinal chemistry | 2005

von Moro, S. | Braiuca, P. | Deflorian, F. | +7